Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - TAX PROVISION
Tax Provision ALNY - Alnylam Pharmaceuticals, Inc.
99.2 M
LAST VALUE
388.19%
2 YEAR CAGR
158.29%
5 YEAR CAGR
16.15%
10 YEAR CAGR